172 related articles for article (PubMed ID: 37146918)
1. Advanced nanoscale drug delivery systems for bone cancer therapy.
Amiryaghoubi N; Fathi M; Barar J; Omidian H; Omidi Y
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166739. PubMed ID: 37146918
[TBL] [Abstract][Full Text] [Related]
2. Bone-Targeted Dual Functional Lipid-coated Drug Delivery System for Osteosarcoma Therapy.
Zhong J; Wen W; Wang J; Zhang M; Jia Y; Ma X; Su YX; Wang Y; Lan X
Pharm Res; 2023 Jan; 40(1):231-243. PubMed ID: 36380167
[TBL] [Abstract][Full Text] [Related]
3. Engineered nanomedicine for myeloma and bone microenvironment targeting.
Swami A; Reagan MR; Basto P; Mishima Y; Kamaly N; Glavey S; Zhang S; Moschetta M; Seevaratnam D; Zhang Y; Liu J; Memarzadeh M; Wu J; Manier S; Shi J; Bertrand N; Lu ZN; Nagano K; Baron R; Sacco A; Roccaro AM; Farokhzad OC; Ghobrial IM
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10287-92. PubMed ID: 24982170
[TBL] [Abstract][Full Text] [Related]
4. Research Progress of Nanomaterials in Chemotherapy of Osteosarcoma.
Yu T; Cai Z; Chang X; Xing C; White S; Guo X; Jin J
Orthop Surg; 2023 Sep; 15(9):2244-2259. PubMed ID: 37403654
[TBL] [Abstract][Full Text] [Related]
5. Polymeric Nanocarriers for Drug Delivery in Osteosarcoma Treatment.
Gu X; Ding J; Zhang Z; Li Q; Zhuang X; Chen X
Curr Pharm Des; 2015; 21(36):5187-97. PubMed ID: 26412359
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles for the treatment and diagnosis of osteosarcoma.
Yuan P; Min Y; Zhao Z
Biomater Adv; 2023 Aug; 151():213466. PubMed ID: 37229927
[TBL] [Abstract][Full Text] [Related]
7. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
8. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.
Shi P; Cheng Z; Zhao K; Chen Y; Zhang A; Gan W; Zhang Y
J Nanobiotechnology; 2023 Mar; 21(1):103. PubMed ID: 36944946
[TBL] [Abstract][Full Text] [Related]
9. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
Li Y; Hou H; Zhang P; Zhang Z
Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
[TBL] [Abstract][Full Text] [Related]
11. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
[TBL] [Abstract][Full Text] [Related]
12. Application of nanoparticles in drug delivery for the treatment of osteosarcoma: focussing on the liposomes.
Liang W; Dong Y; Shao R; Zhang S; Wu X; Huang X; Sun B; Zeng B; Zhao J
J Drug Target; 2022 Jun; 30(5):463-475. PubMed ID: 34962448
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery nanocarriers and recent advances ventured to improve therapeutic efficacy against osteosarcoma: an overview.
Desai SA; Manjappa A; Khulbe P
J Egypt Natl Canc Inst; 2021 Feb; 33(1):4. PubMed ID: 33555490
[TBL] [Abstract][Full Text] [Related]
14. Carbon nanotubes for delivery of small molecule drugs.
Wong BS; Yoong SL; Jagusiak A; Panczyk T; Ho HK; Ang WH; Pastorin G
Adv Drug Deliv Rev; 2013 Dec; 65(15):1964-2015. PubMed ID: 23954402
[TBL] [Abstract][Full Text] [Related]
15. Ceramic core with polymer corona hybrid nanocarrier for the treatment of osteosarcoma with co-delivery of protein and anti-cancer drug.
Prasad SR; Kumar TSS; Jayakrishnan A
Nanotechnology; 2018 Jan; 29(1):015101. PubMed ID: 29130895
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
Metin E; Mutlu P; Gündüz U
Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
[TBL] [Abstract][Full Text] [Related]
18. PLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.
Bao W; Liu R; Wang Y; Wang F; Xia G; Zhang H; Li X; Yin H; Chen B
Int J Nanomedicine; 2015; 10():557-66. PubMed ID: 25609961
[TBL] [Abstract][Full Text] [Related]
19. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy.
Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM
J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857
[TBL] [Abstract][Full Text] [Related]
20. Co-nanoencapsulated doxorubicin and Dz13 control osteosarcoma progression in a murine model.
Tan ML; Friedhuber AM; Dass CR
J Pharm Pharmacol; 2013 Jan; 65(1):35-43. PubMed ID: 23215686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
